HIV molecular immunology database
Databases
Sequence DB
Immunology DB
Vaccine Trials DB
HCV Databases
HFV Databases
Search
CTL/CD8+ Search
T Helper/CD4+ Search
Antibody Search
CTL Variant Search
T Helper Variant Search
Search Help
Tools
All Immunology Tools
CATNAP
CombiNAber
HIV Genome Browser
Quickalign
Analyze Align
Algnment Slicer
PeptGen
PepMap
Motif Scan
Hepitope
HLA Freq Analysis
ELF
Sequence Locator
SeqPublish
Heatmap
Epigraph Vaccine Suite
Mosaic Vaccine Suite
N-Glycosite
Highlighter
Protein Feature Accent
Variable Region
Products
Epitope Maps
Epitope Tables
Epitope Alignments
T Cell Epitope Variants
Neutralizing Ab Resources
& CATNAP
Data Sets: HLA Typing and
Epitope Mapping
Tools & Links
Publications
Compendia
Reviews
About the Database
FAQ
How to Cite this Database
Sequence Alignments
Sequence Database Tutorials
Search CTL/CD8+ T-Cell Epitope Database
HIV protein
- ALL -
Gag
p17
p24
p2p7p1p6
Gag/Pol
Pol
Gag/Pol-TF
Protease
RT
Integrase
Vif
Vpr
Tat
Rev
Vpu
gp160
Env
Nef
Cryptic
HIV-1
gp120
gp41
HXB2 protein location
—
Results overlap with query location
Results contained within query location
Results exactly match query location
HXB2 DNA location
—
Results overlap with query location
Epitope
Results contain query sequence
Results exactly match query sequence
Results fuzzy match to query sequence
Epitope name
Record number
Subtype
- ALL -
A
A1
B
BC
C
CRF01_AE
CRF02_AG
CRF06_cpx
CRF09_cpx
D
F
F1
G
H
HIV-2
J
K
M
M-group
multiple
U
Immunogen
- ALL -
computer prediction
HIV-1 and HCV co-infection
HIV-1 exposed seronegative
HIV-1 infected monocyte-derived
HIV-1 infection
HIV-1 or HIV-2 infection
HIV-2 infection
in vitro stimulation or selection
peptide-HLA interaction
SHIV infection
SIV infection
vaccine
virus
Vaccine details
if Immunogen is Vaccine
Vaccine type
- ALL -
adeno-associated virus (AAV)
adenovirus
adenovirus type 5 (Ad5)
AIDSVAX B/E
alphavirus replicon
ALVAC-HIV
attenuated poxvirus vector NYVAC
B. abortus complex
Bacillus BCG prime with vaccinia Ankara (MVA) boost
bacteriophage coat protein
canarypox
canarypox prime with gp120 boost
canarypox prime with gp160 boost
canarypox prime with pseudovirion boost
canarypox prime with recombinant protein boost
coxsackievirus
dihydrolipoyl acetyltransferase E2 protein, of Bacillus stearothermophilus
DNA
DNA prime with Ad5 boost
DNA prime with gp120 boost
DNA prime with gp160 boost
DNA prime with modified vaccinia Ankara (MVA) boost
DNA prime with peptide boost
DNA prime with poxvirus boost
DNA prime with vaccinia boost
DNA prime with virus-like particle (VLP) boost
DNA with CMV promotor
DNA with CMV promotor with cationic liposome
DNA with protein boost
fowlpox prime with modified vaccinia Ankara (MVA) boost
fowlpoxvirus
fusion protein with anthrax delivery domain
gp120 depleted whole killed virus
gp160 prime with gp120 boost
hemagglutinating virus of Japan (HVJ)-liposome
hepatitis B surface antigen lipoprotein particles (HsBAg)
herpes simplex virus type-1 (HSV-1) amplicon
HIV-1 peptide in filamentous bacteriophage major coat protein
HIVconsv
influenza
influenza prime with vaccinia boost
ISCOM
lipopeptide
liposome
Listeria monocytogenes
Long Peptides
measles virus (MV)
Mengo virus
modified vaccinia Ankara (MVA)
nanoparticle
non-replicating adenovirus
other
peptide
peptide in liposome
PLG microparticle
polyepitope
poxvirus
protein
rabies virus
Salmonella
Semliki-Forest Virus
Semliki-Forest Virus with virus-like particle boost
Sendai virus vector system (SeV)
Sindbis
vaccinia
vaccinia prime DNA boost
vaccinia prime with gp120 boost
vaccinia prime with gp160 boost
vaccinia with H1 influenza HA gene cassette
vesicular stomatitis virus (VSV)
virus-like particle (VLP)
Vaccine strain
- ALL -
A clade
A clade 92RW020
A clade consensus
A clade UG5.94UG018
AE clade
AG recombinant HZ321
B clade
B clade 89.6
B clade 89.6P
B clade ADA
B clade ARV-2
B clade BH10
B clade BRU
B clade BRVA
B clade CAM-1
B clade consensus
B clade HXB2
B clade HXB3
B clade HXBc2
B clade IIIB
B clade JRFL
B clade JY1
B clade LAI
B clade LR150
B clade MN
B clade NL43
B clade RF
B clade SC
B clade SF162
B clade SF2
B clade SIMI
B clade W61D
C clade
C clade 96ZM651
C clade 97CN54
C clade 97ZA012
C clade C-96BW04.09
C clade C-96BW15C05
C clade consensus
C clade Du151
C clade Du422
CRF02 IC0928
CRF12 ARMA159
D clade
D clade NDK
HIV-2 VLP
M group consensus
multiple epitope immunogen
natural variants
other
SIV
ZF1
Vaccine component
- ALL -
anchored gp120
CD4BS
complete genome
ΔV2Env
Env
Gag
Gag-Pol
gp120
gp120 depleted virus
gp140
gp140ΔCFI
gp140ΔV2
gp140ΔV3
gp160
gp160 deletions
gp160ΔV3
gp41
HIV-1
HPG30
mimotopes
Nef
Nef-Tat
oligomeric gp140
Other
p17 Gag
p17/p24 Gag
p18 Gag
p24 Gag
p24-Nef
Pol
Protease
Rev
RT
Tat
V3
Vif
Vpr
Vpu
Adjuvant
- ALL -
aluminum hydroxide
aluminum phosphate
B7
B. anthracia lethal toxin LF component
beta-glucan lentinan
block copolymer CRL8623
Bupivacaine
CAF01
cationic block copolymer K2
cationic liposome
CD40
CD80
CD86
Cholera toxin (CT)
Complete Freund's Adjuvant (CFA)
concavalin A-immobilized polystyrene nanospheres
CpG immunostimulatory sequence (ISS)
DDA
DOTAP
E. coli heat labile enterotoxin
E. coli mutant heat labile enterotoxin (LT-R72)
Flex, a dendric cell growth factor
FLt3 ligand (FL)
GM-CSF
gp41 N-HR and C-HR helical peptides
HSP70
ICAM
IFNγ
IL-12
IL-15
IL-18
IL-1α
IL-2
IL-2/Ig
IL-4
Immune stimulating complexes (ISCOM)
Incomplete Freund's Adjuvant (IFA)
in vivo electroporation
LFA-3
lipopolysaccharide (LPS)
liposome
LTK63
macrophage activating lipopeptide (MALP)
MF59
MIP-1α
Montanide (ISA 51)
Montanide (ISA 720)
oligomannose
Other
P30
PLG
poly(I:C)
QS21
red blood cells
reovirus alpha 1 protein
Ribi adjuvant (MPL+TDM) (RIBI)
urea
vesicular stomatitis virus glycoprotein (VSV-G)
Species
- ALL -
baboon
chimpanzee
goat
guinea pig
human
humanized mouse
humanized rabbit
macaque
mouse
rabbit
scid-hu mouse
transgenic mouse
MHC/HLA
- ALL -
A*01
A*0101
A*0123
A*02
A*0201
A*02.01
A*020101
A*0202
A*0205
A*0206
A*0207
A*0214
A*0217
A*03
A*0301
A03 supertype
A*0801
A1
A11
A*11
A*1101
A*1103
A11.1
A19
A2
A2.1
A23
A*23
A*2301
A24
A*24
A*2402
A25
A*25
A*2501
A26
A*26
A*2601
A*2602
A*2603
A*2638
A*2705
A28
A28 supertype
A29
A*29
A*2902
A2 supertype
A3
A3?
A30
A*30
A*3001
A*3002
A31
A*31
A*3101
A32
A*32
A*3201
A33
A*33
A*3301
A*3303
A*34
A*3402
A*36
A3 supertype
A*4002
A*4301
A66
A*66
A68
A*68
A*6801
A*6802
A68 supertype
A*69
A74
A*74
A*7401
A*80
B*07
B*0702
B*0705
B*08
B*0801
B12
B13
B*13
B*1302
B14
B*14
B*1401
B*1402
B*1403
B15
B*15
B*1501
B*1502
B*1503
B*1510
B*1516
B*1517
B*1524
B*1540
B17
B18
B*18
B*1801
B27
B*27
B*2703
B*2705
B35
B*35
B*3501
B*3502
B*3503
B*3505
B*3508
B37
B*37
B*3701
B38
B*38
B*3801
B39
B*39
B*3901
B*3910
B40
B*40
B*4001
B*4002
B*4006
B*41
B42
B*42
B*4201
B*4202
B44
B*44
B*4402
B*4403
B*440301
B*4415
B45
B*45
B*4501
B*4801
B49
B*49
B*4901
B5
B50
B*50
B*5001
B51
B*51
B*5101
B52
B*52
B*5201
B53
B*53
B*5301
B*54
B*5401
B55
B*55
B*5501
B56
B57
B*57
B*5701
B*5702
B*5703
B*570301
B58
B*58
B*5801
B*5802
B60
B*60
B61
B*61
B62
B*62
B62?
B63
B*63
B*6701
B*68
B7
B7?
B70
B*70
B71
B*73
B*78
B7 supertype
B8
B81
B*81
B*8101
B*82
C*01
C*02
C*03
C*0304
C*04
C*05
C*06
C*07
C*08
C*12
C*14
C*15
C*16
C*17
C*18
Cw*01
Cw*0102
Cw*0202
Cw*03
Cw*0303
Cw*0304
Cw*04
Cw*0401
Cw*0407
Cw*05
Cw*0501
Cw*06
Cw*0602
Cw*07
Cw*0701
Cw*0702
CW*0702
Cw*0704
Cw*08
Cw*0801
Cw*0802
Cw*0804
Cw1
Cw12
Cw*12
Cw*1202
Cw*1203
Cw*14
Cw*1402
Cw15
Cw*15
Cw*1701
Cw18
Cw*18
Cw*1801
Cw2
Cw3
Cw4
Cw5
Cw6
Cw7
Cw8
DPw4.2
DR1
DR4
DRA
H-2d
H-2D
H-2D
b
H-2D
d
H-2D
p
H-2D
q
H-2K
d
H-2K
k
H-2L
d
H-2
a
H-2
b
H-2
bxd
H-2
d17
H-2
d
H-2
f
H-2
kd
H-2
k
H-2
p
H-2
q
H-2
u
Mamu A*01
Mamu-A*01
Mamu-A*11
Mamu-B*03
Mamu-B*04
Mamu-B*17
not B8
Patr-B*02
Patr-B*03
Patr-B*14
Author
First
Last
Country
- ALL -
Argentina
Australia
Barbados
Belgium
Botswana
Brazil
Burkina Faso
Cameroon
Canada
Chile
China
Cote D'Ivoire
Democratic Republic of the Congo
Denmark
Dominican Republic
Ethiopia
Finland
France
Gambia
Germany
Ghana
Guinea-Bissau
Haiti
India
Italy
Jamaica
Japan
Kenya
Korea, Republic of
Malawi
Mali
Mexico
Mozambique
Netherlands
Nigeria
Pakistan
Peru
Philippines
Puerto Rico
Senegal
Somalia
South Africa
Spain
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Uganda
United Kingdom
United States
Viet Nam
Zambia
Zimbabwe
Keywords
- ALL -
acute/early infection
adjuvant comparison
antagonism
antibody binding site definition and exposure
antibody generation
assay development, comparison, standardization, improvement
autologous responses
binding affinity
bispecific molecule
broad neutralizer
CD4+ CTL
cell-line isolated antibody
characterizing CD8+ T cells
chronic infection
class I down-regulation by Nef
compensatory mutation
computational epitope prediction
co-receptor
cross-presentation by different HLA
cryptic epitope
dendritic cells
drug resistance
dynamics
early-expressed proteins
early treatment
elite controllers
enhancing activity
epitope processing
escape
genital and mucosal immunity
HAART, ART
HIV-2
HIV exposed persistently seronegative (HEPS)
HLA associated polymorphism
immunodominance
immunotherapy
junction or synthetic peptide
kinetics
memory cells
mimotopes
mother-to-infant transmission
mutation acquisition
neutralization by CTL
NK cells
non-susceptible form
novel epitope
optimal epitope
rate of progression
responses in children
review
SIV
structure
subtype comparisons
superinfection
supertype
supervised treatment interruptions (STI)
T-cell crossreactivity to human proteins
TCR usage
Th1
Th2
therapeutic vaccine
vaccine antigen design
vaccine-induced immune responses
variant cross-recognition or cross-neutralization
viral fitness and reversion
Note
Click for
Search Help
Search CTL/CD8+ variants
Questions or comments? Contact us at
immuno@lanl.gov
